PHENOTYPES AND RISK FACTORS OF ANEMIA IN PRE END STAGE RENAL DISEASE CONCOMITANT WITH ULTRASONOGRAPHIC EVALUATION OF THE KIDNEY.

Main Article Content

Ayman S. A. M. Ayad
Alshaimaa Sobhy Aboshady
Mohamed Sabry Amer
Basem Abd El-hamid
Hamdy S.A. Othman
Ahmed M. Mustafa
Ayman N. Mostafa
Elsayed Mohamed Abd El-Hamid Hassan
Mohamed A. Younes
Fatma Mohamed Ramadan Ibrahim Negm
Ola Ahmed Bahgat
Mohamed Abdul Fattah Elasalamoni
Suzan Eid Elshishtawy Ibrahim

Keywords

chronic kidney disease (CKD), pre-end-stage renal disease, Anemia, erythropoiesis,

Abstract

Background: Non-glomerular kidney disease is classified as progressive or end-stage renal disease (ESRD), with chronic anemia frequently arising from the progression of chronic renal insufficiency, often addressed by insufficient erythropoiesis stimulation.


Aim: This study aimed to investigate the phenotypes and risk factors of anemia in patients with pre-end-stage renal disease as well as to conduct ultrasonographic assessments of the kidneys to identify underlying etiologies and to assess disease chronicity.


Method: This research investigated the prevalence of anemia in 50 patients with chronic kidney disease (CKD) at Al-Azhar University Hospitals.  The patients were categorized into two groups: individuals with chronic kidney disease (CKD) and those not undergoing therapy or dialysis.  The control group comprised 20 healthy participants.  All patients and controls participated in a comprehensive evaluation, encompassing medical history, physical examination, laboratory tests and abdominal ultrasonography. 


Results: The results indicated no significant disparities in demographic and anthropometric variables between the CKD patient cohort and the healthy control cohort. Diabetes Mellitus and Hypertension were the predominant co-morbidities among CKD patients, impacting 52% of the group. All CKD patients exhibited anemia, with the predominant anemia phenotype being Normocytic-Normochromic Anemia (NNA) at 72%. Prevalent risk factors for anemia in chronic kidney disease patients encompassed elevated CRP, ESR, blood urea, serum creatinine, diminished GFR, heightened serum ferritin, anorexia, positive occult blood in stool, and erythropoietin insufficiency.


Conclusion: A study of 70 Egyptian volunteers found anemia prevalent in pre-ESRD patients, with diabetes and hypertension being the main causes. The study highlights the need for further research.

Abstract 76 | Pdf Downloads 22

References

1. Agarwal, A. K. (2021). Iron metabolism and management: focus on chronic kidney disease. Kidney international supplements, 11(1), 46-58.
2. Baaten, C. C., Sternkopf, M., Henning, T., Marx, N., Jankowski, J., & Noels, H. (2021). Platelet function in CKD: a systematic review and meta-analysis. Journal of the American Society of Nephrology, 32(7), 1583-1598.
3. Bissinger, R., Nemkov, T., D'Alessandro, A., Grau, M., Dietz, T., Bohnert, B. N., ... & Artunc, F. (2021). Proteinuric chronic kidney disease is associated with altered red blood cell lifespan, deformability and metabolism. Kidney international, 100(6), 1227-1239.
4. Hanna, R. M., Streja, E., & Kalantar-Zadeh, K. (2021). Burden of anemia in chronic kidney disease: beyond erythropoietin. Advances in therapy, 38(1), 52-75.
5. Hao, C. M., Wittbrodt, E. T., Palaka, E., Guzman, N., Dunn, A., & Grandy, S. (2021). Understanding patient perspectives and awareness of the impact and treatment of anemia with chronic kidney disease: a patient survey in China. International Journal of Nephrology and Renovascular Disease, 53-64.
6. Ianni, C. M., McDowall, M. P., & Zuska, I. A. (2021). Differential diagnosis of low hemoglobin. Dimensions of Critical Care Nursing, 40(4), 204-209.
7. Islam, K. M., Ajmery, S., Huda, M., Saleh, S., Jyoti, B. K., & Saha, T. (2021). Prevalence of Anemia in Chronic Kidney Disease. Medicine Today, 33(1), 54-57.
8. Kalyesubula, R. (2021). Characterization of kidney disease in sub-Saharan Africa (Doctoral dissertation, London School of Hygiene & Tropical Medicine).
9. Klinkhammer, B. M., Lammers, T., Mottaghy, F. M., Kiessling, F., Floege, J., & Boor, P. (2021). Non-invasive molecular imaging of kidney diseases. Nature Reviews Nephrology, 17(10), 688-703.
10. Lippi, I., Perondi, F., Lubas, G., Gori, E., Pierini, A., D’Addetta, A., & Marchetti, V. (2021). Erythrogram patterns in dogs with chronic kidney disease. Veterinary Sciences, 8(7), 123.
11. MacIsaac, S., Ramanakumar, A. V., Saw, C., Naessens, V., Saberi, N., Cantarovich, M., ... & Sandal, S. (2021). Relative decrease in hemoglobin and outcomes in patients undergoing kidney transplantation surgery: A retrospective cohort study. The American Journal of Surgery, 222(4), 825-831.
12. Mahmoud, T., & Borgi, L. (2021, March). The interplay between nutrition, metabolic, and endocrine disorders in chronic kidney disease. In Seminars in Nephrology (Vol. 41, No. 2, pp. 180-188). WB Saunders.
13. Mejia, J. R., Fernandez-Chinguel, J. E., Dolores-Maldonado, G., Becerra-Chauca, N., Goicochea-Lugo, S., Herrera-Añazco, P., ... & Taype-Rondan, A. (2021). Diagnostic accuracy of urine dipstick testing for albumin-to-creatinine ratio and albuminuria: A systematic review and meta-analysis. Heliyon, 7(11).
14. Michalak, S. S., Wolny-Rokicka, E., Nowakowska, E., Michalak, M., & Gil, L. (2021). Clinical implications of the coexistence of anemia and diabetes mellitus in the elderly population. Journal of Diabetes Research, 2021(1), 8745968.
15. Portolés, J., Martín, L., Broseta, J. J., & Cases, A. (2021). Anemia in chronic kidney disease: from pathophysiology and current treatments, to future agents. Frontiers in Medicine, 8, 642296..
16. Portolés, J., Martín, L., Broseta, J. J., & Cases, A. (2021). Anemia in chronic kidney disease: from pathophysiology and current treatments, to future agents. Frontiers in Medicine, 8, 642296.
17. Robba, C., Wong, A., Poole, D., Al Tayar, A., Arntfield, R. T., Chew, M. S., ... & Vieillard-Baron, A. (2021). Basic ultrasound head-to-toe skills for intensivists in the general and neuro intensive care unit population: consensus and expert recommendations of the European Society of Intensive Care Medicine. Intensive care medicine, 47, 1347-1367.
18. Rosner, M. H., Reis, T., Husain-Syed, F., Vanholder, R., Hutchison, C., Stenvinkel, P., ... & Ronco, C. (2021). Classification of uremic toxins and their role in kidney failure. Clinical Journal of the American Society of Nephrology, 16(12), 1918-1928.
19. Scavello, I., Maseroli, E., Cipriani, S., Di Stasi, V., Verde, N., Menafra, D., ... & Vignozzi, L. (2021). Cardiometabolic risk is unraveled by color Doppler ultrasound of the clitoral and uterine arteries in women consulting for sexual symptoms. Scientific reports, 11(1), 18899.
20. Shi, M., Li, Y. Y., Xu, R. N., Meng, F. P., Yu, S. J., Fu, J. L., ... & Wang, F. S. (2021). Mesenchymal stem cell therapy in decompensated liver cirrhosis: a long-term follow-up analysis of the randomized controlled clinical trial. Hepatology international, 15, 1431-1441.
21. Shih, H. M., Wu, C. J., & Lin, S. L. (2018). Physiology and pathophysiology of renal erythropoietin-producing cells. Journal of the Formosan Medical Association, 117(11), 955-963.
22. Thiagarajan, P., Parker, C. J., & Prchal, J. T. (2021). How do red blood cells die?. Frontiers in physiology, 12, 655393.
23. Vigneshwaran, S. (2021). Clinical Profile Of Anemia And Its Impact On Functional Capacity And Cognition In Elderly” Submitted In Partial Fulfillment Of MD Degree Examination Geriatrics (Doctoral dissertation, BLDE (Deemed to be University)).
24. Weir, M. R. (2021). Managing anemia across the stages of kidney disease in those hyporesponsive to erythropoiesis-stimulating agents. American Journal of Nephrology, 52(6), 450-466.
25. Yan, M. T., Chao, C. T., & Lin, S. H. (2021). Chronic kidney disease: strategies to retard progression. International journal of molecular sciences, 22(18), 10084.
26. Yoshimura, Y., Wakabayashi, H., Shiraishi, A., Nagano, F., Bise, T., & Shimazu, S. (2021). Hemoglobin improvement is positively associated with functional outcomes in stroke patients with anemia. Journal of Stroke and Cerebrovascular Diseases, 30(1), 105453.

Most read articles by the same author(s)